LUNDBERG MAGNUS 4
4 · ONYX PHARMACEUTICALS INC · Filed Apr 3, 2013
Insider Transaction Report
Form 4
LUNDBERG MAGNUS
Director
Transactions
- Sale
Common Stock
2013-04-01$92.00/sh−10,000$920,000→ 14,216 total - Exercise/Conversion
Stock Option (Right to Buy)
2013-04-01−10,000→ 0 totalExercise: $23.70From: 2006-06-08Exp: 2015-06-08→ Common Stock (10,000 underlying) - Exercise/Conversion
Common Stock
2013-04-01$23.70/sh+10,000$237,000→ 24,216 total
Footnotes (1)
- [F1]Shares sold pursuant to a 10b5-1 plan.